PMC5078653_01
Skin cancers before and after introduction of everolimus in heart transplant recipients. Mean follow-up after start of everolimus was 28 months (range 16 to 37 months). The number of lesions before everolimus is shown for the preceding 28 months. SCC, squamous cell carcinoma; BCC, basal cell carcinoma; BD, Bowen's disease; AK, actinic keratosis.
JTRANS2016-4369574.003.jpg
PMC5078653_01_JTRANS2016-4369574.003.jpg
fig3
The number of skin tumors which developed after over a mean of 28 months after starting everolimus was significantly lower than in the preceding 28 months (Figure 3).